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We appreciate Michael Millenson's critique of our decision to seek consent from developers of mobile health applications (mHealth apps) to name their apps in our study (Dec 2016 ). While we agree that mHealth apps may have an impact on health, we note that the apps we evaluated generally would not qualify as medical devices, based on the Food and Drug Administration's guidance.
1
Several factors contributed to our decision not to name apps without developer consent. At the outset of our research, we anticipated that a number of selected apps would require login credentials because they were linked to specific health care institutions. To incentivize developers to provide us with login credentials, we decided to request permission from developers to name their apps in our study. At the advice of our legal team and to be fair and consistent, we used an opt-in consent process for all app developers, not just those whose apps required login credentials. In the end, we were unable to review nine apps because we could not obtain such credentials. To be clear, we asked developers for permission simply to name their apps-not to review them or include them in the analysis.
We see the value in sharing our results and also endorse transparency more broadly in evaluations of applications, so we have posted our results online.
2 The apps we did not receive permission to name are included in the data set but left unnamed. 
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